- Markers of inflammation in acute and chronic phase of myocardial infarction2004 | Faculty of Physical Education and Sport
- Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice2021 | Publication without faculty affiliation
- Imatinib in the first-line treatment of chronic myelogenous leukemia in chronic phase2008 | First Faculty of Medicine
- Imatinib in the first-line treatment of chronic myelogenous leukemia in chronic phase2008 | Publication without faculty affiliation
- Imatinib mesylate (Glivec) in treatment of chronic myeloid leukemia in chronic phase2004 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Markers of inflammation in acute and chronic phase of myocardial infarctionPublication without faculty affiliation
- IMATINIB in the treatment of elderly patients with Ph+ CML in the late chronic phasePublication without faculty affiliation
- Czech experience with Glivec in treatment of chronic myeloid leukemia in chronic phase2003 | Publication without faculty affiliation
- Glivec impact on MCV in patients with chronic phase of chronic myeloid leukemiaPublication without faculty affiliation
- Antibodies to Chlamydia pneumoniae in acute and chronic phase of myocardial infarction treated with PTCAPublication without faculty affiliation
- Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib2017 | Publication without faculty affiliation
- Prognostic significance of cytogenetic abnormalities in patients in chronic phase of chronic myeloid leukemia treated with imatinibPublication without faculty affiliation
- The Involvement of the Amadeo Instrument into a Standard Therapy in Patiens after Brain Vascular Event in the Chronic Phase: A Follow up Study2017 | First Faculty of Medicine
- Comparison of cytogenetic and molecular genetic methods in patients in chronic phase of chronic myeloid leukemia (CML) treated with imatinibe mesylatePublication without faculty affiliation
- Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase2015 | First Faculty of Medicine
- Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy2022 | Second Faculty of Medicine
- Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications2013 | Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia2010 | Faculty of Medicine in Hradec Králové
- Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic2010 | Faculty of Physical Education and Sport, Faculty of Medicine in Hradec Králové
- Diffusion parameters of extracellular space in rat brain and spinal cord during development and pathological statesPublication without faculty affiliation
- Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation2006 | Second Faculty of Medicine
- The therapeutic potential of targeting CD40-TRAF6 pathway in cardiovascular diseases Response2019 | Faculty of Medicine in Pilsen
- De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors2024 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Central Library of Charles University
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CAMN107EIC01Publication without faculty affiliation
- Research Report University Hospital for clinical assessment CA180399Publication without faculty affiliation
- Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic2010 | First Faculty of Medicine
- Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party2016 | Publication without faculty affiliation
- Spinal Cord Injury : Causes, Consequences, Care management2019 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine
- Surgical Treatment of Cervical Spondylodiscitis2021 | First Faculty of Medicine, Third Faculty of Medicine
- Vestibular rehabilitation - principles of rehabilitation of patients with disorders of the vestibular system2007 | Second Faculty of Medicine
